Daily Longevity Drink Improved Blood Vessel Health in Trial
NEW YORK – November 04, 2026 -- A daily drink mix called NOVOS Core improved blood vessel function, arterial flexibility and systolic blood pressure in healthy adults aged 40 and older over six months, according to a randomized trial published in the European Heart Journal Open.
The STAMINA trial was led by Professor Christian Heiss of the University of Surrey, together with colleagues at Royal Surrey NHS Foundation Trust. It was double-blind and placebo-controlled. Participants already had measures within normal ranges, which leaves little room for improvement.
Three vascular measures improved against placebo
Flow-mediated dilation (FMD), the primary endpoint that tracks how well arteries widen as blood flow increases, rose 47% from baseline in the NOVOS Core group. The adjusted improvement versus placebo was 2.9 percentage points.